Disseminated Xanthogranuloma with BRAF Gene Fusion and Profound Response to MEK Inhibitor Therapy
Olga Lytvynova(Cleveland Clinic), Ariel Sindel(Cleveland Clinic), Mark C. Mochel(Children's Hospital of Richmond at VCU), Hetal Ravikumar Vachhani(Children's Hospital of Richmond at VCU), Abe Abdulhak(Children's Hospital of Richmond at VCU), Nutan Nutan(Children's Hospital of Richmond at VCU), Freba Farhat(Children's Hospital of Richmond at VCU), Andrew Poklepovic(Virginia Commonwealth University)
Cited by 3
Related Papers
Phase I study of pemetrexed with sorafenib in advanced solid tumors
|Oncotarget|2016|8
Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma
|Antibodies|2024|4